miR-26 binds to the 3'UTR of the ABCA1 mRNA

Stable Identifier
Reaction [binding]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Micro RNA miR-26 was identified as a liver X receptor (LXR or NR1H2,3)-repressed miRNA in macrophage cell lines (Sun D et al. 2012). miR-26 suppressed translation of ATP-binding cassette transporter A1 (ABCA1) mRNA in NR1H2,3 (LXR)‐activated human (THP-1) and mouse (RAW264.7) macrophage cell lines. Bioinformatic tools for miRNA target prediction identified a highly conserved seed regions for miR‐26a and miR‐26b in the 3′UTR of the ABCA1 transcript that was confirmed by 3’UTR luciferase assay methods (Sun D et al. 2012). Moreover, miR‐26 was shown to reduce cellular ABCA1 protein levels and abrogate NR1H2,3‐dependent cholesterol efflux in RAW264.7 cells by targeting ABCA1 and ARL4C (ARL7) mRNA (Sun D et al. 2012). Conversely, treating RAW cells with miR-26 inhibitors, increased ABCA1 protein levels, and enhanced LXR agonist-mediated cholesterol efflux (Sun D et al. 2012). TheThe Reactome event describes the miR-26- regulated translation of ABCA1 mRNA in response to NR1H2,3 natural ligands. The annotation is based on the study with GW3965 and T0901317, the synthetic agonists of NR1H2,3 (Sun D et al. 2012).

Literature References
PubMed ID Title Journal Year
22673513 MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7

Xie, J, Zhang, J, Chen, M, Zhao, X, Sun, D, Wei, W

FEBS Lett. 2012
Cite Us!